FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Terry Dagnon, chief operations officer for Outlook Therapeutics, discusses the latest update on ONS-5010 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Eighty percent of patients could go 6 months without an ...

We report a case of a 50-year-old diabetic male patient with diabetic macular edema. He received intravitreal injections of Bevacizumab for five times: three to his right eye and two to the left eye.